Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00495170 · ClinicalTrials.gov registry record · Phase 2
Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 84
- Enrollment target
NCT00495170: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT00495170 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00495170, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 84 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if proton radiotherapy given with standard chemotherapy (such as paclitaxel and carboplatin) can help to control locally advanced NSCLC. The safety of this treatment will also be studied.
Interventions
- DRUG Carboplatin
- DRUG Paclitaxel
- RADIATION Proton Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2006-04-14 |
| Est. Completion | 2017-06-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00495170
The ClinicalTrials.gov registry entry for NCT00495170 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Carboplatin is the first listed.
NCT00495170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00495170 about?
NCT00495170 is a clinical study titled "Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)". The goal of this clinical research study is to learn if proton radiotherapy given with standard chemotherapy (such as paclitaxel and carboplatin) can help to control locally advanced NSCLC. The safety of this treatment will also be studied.
What is the current status of trial NCT00495170?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 84 participants. The study started on 2006-04-14. Estimated completion is 2017-06-14.
What interventions are being tested in trial NCT00495170?
The interventions under investigation include: Carboplatin (DRUG), Paclitaxel (DRUG), Proton Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT00495170?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.